KEGG   DRUG: Empasiprubart
Entry
D12992                      Drug                                   
Name
Empasiprubart (USAN/INN)
Formula
C6454H9980N1720O2042S44
Exact mass
145659.7679
Mol weight
145749.54
Sequence
(Heavy chain)
EVQLVQSGAE VKKPGASVKV SCKASGYTFT DYNMDWVRQA TGQGLEWIGD INPNYESTGY
NQKFKGRATM TVDKSISTAY MELSSLRSED TAVYYCARED DHDAFAYWGQ GTLVTVSSAS
TKGPSVFPLA PSSKSTSGGT AALGCLVKDY FPEPVTVSWN SGALTSGVHT FPAVLQSSGL
YSLSSVVTVP SSSLGTQTYI CNVNHKPSNT KVDKKVEPKS CDKTHTCPPC PAPEAAGGPS
VFLFPPKPKD TLMISRTPEV TCVVVDVSHE DPEVKFNWYV DGVEVHNAKT KPREEQYNST
YRVVSVLTVL HQDWLNGKEY KCKVSNKALP APIEKTISKA KGQPREPQVY TLPPSRDELT
KNQVSLTCLV KGFYPSDIAV EWESNGQPEN NYKTTPPVLD SDGSFFLYSK LTVDKSRWQQ
GNVFSCSVMH EALKFHYTQK SLSLSPG
(Light chain)
DNVLTQSPDS LAVSLGERAT ISCRASKSVR TSGYNYMHWY QQKPGQPPKL LIYLASNLKS
GVPDRFSGSG SGTDFTLTIS SLQAEDAATY YCQHSRELPY TFGQGTKLEI KRTVAAPSVF
IFPPSDEQLK SGTASVVCLL NNFYPREAKV QWKVDNALQS GNSQESVTEQ DSKDSTYSLS
STLTLSKADY EKHKVYACEV THQGLSSPVT KSFNRGEC
(Disulfide bridge: H22-H96, H145-H201, H221-L218, H227-H'227, H230-H'230, H262-H322, H368-H426, H'22-H'96, H'145-H'201, H'221-L'218, H'262-H'322, H'368-H'426, L23-L92, L138-L198, L'23-L'92, L'139-L'198)
  Type
Peptide
Efficacy
Immunosuppressant
  Type
Monoclonal antibody
Comment
Treatment of complement mediated diseases
Target
C2 [HSA:717] [KO:K01332]
  Pathway
hsa04610  Complement and coagulation cascades
Brite
Target-based classification of drugs [BR:br08310]
 Peptidases and inhibitors
  Serine peptidases
   Chymotrypsin family
    C2
     D12992  Empasiprubart (USAN/INN)
Other DBs
CAS: 2579031-19-7
PubChem: 504099508
LinkDB

» Japanese version   » Back

DBGET integrated database retrieval system